Eating disorders and substance use disorders can occur together. Understanding that overlap requires more than a headline percentage: the eating-disorder diagnosis, substance-related outcome, study population, and treatment setting all affect what a finding means. Evidence about anorexia nervosa cannot automatically describe every eating disorder, and reported substance use is not the same outcome as a diagnosed substance use disorder.
For adults in GA and their loved ones, these distinctions help separate useful health information from assumptions about an individual. Research can establish that co-occurrence deserves attention without identifying a person's diagnosis, explaining why their concerns developed, or determining which services they need.
What does co-occurrence mean for eating disorders?
Co-occurrence means that an eating disorder and a substance use disorder are present in the same person; it does not make them one condition. An individualized addiction treatment plan considers assessed health needs rather than a program label alone. A conversation with River City Recovery admissions can clarify its outpatient scope, but does not establish specialty eating-disorder care.
The National Institute of Mental Health eating-disorder overview, last reviewed in December 2024 and accessed November 6, 2026, describes eating disorders as serious illnesses involving severe disturbances in eating behaviors. It distinguishes these illnesses from occasional concerns about health, weight, or appearance. Weight alone is therefore not an adequate summary of what the overview describes: behaviors and persistent preoccupation also matter.
NIMH identifies substance use disorders among the mental illnesses that can accompany eating disorders, alongside depression and anxiety. It also states that co-occurring conditions can make eating disorders worse. This establishes the importance of recognizing accompanying concerns, not a rule that everyone with an eating disorder has another diagnosis.
Research terminology needs equally careful attention. The anorexia review separates substance use from substance use disorders and distinguishes total SUD estimates from drug abuse or dependence estimates that may exclude alcohol. Those categories answer different questions:
- Eating-disorder diagnosis: identifies the condition studied, not whether a substance use disorder is also present.
- Substance use: describes the behavior measured by a study and does not automatically establish a disorder.
- Substance use disorder: concerns the diagnostic or abuse/dependence categories used in the research.
- Co-occurrence: describes conditions appearing together without establishing which came first or what caused either one.
These distinctions prevent ordinary exposure measures, such as reported alcohol consumption, from being interpreted as addiction diagnoses. They also prevent the opposite mistake: assuming that an eating-disorder diagnosis makes substance-related assessment unnecessary.
What did the anorexia nervosa research find?
A systematic review found a meaningful overlap between anorexia nervosa and substance use disorders, with different pooled estimates for anorexia subtypes. Those findings inform the questions considered in whole-person addiction care planning; they do not determine personal risk or establish suitability for the services discussed through River City Recovery's outpatient admissions contact.
The December 2021 systematic review and meta-analysis of substance use in anorexia nervosa, accessed November 6, 2026, included 52 studies and 14,695 people identified as having anorexia nervosa. Their mean age was 22.82 years, and 95.6% were female. The evidence included adolescent as well as adult samples, so it was not an exclusively adult review.
The included studies were published between 1983 and 2019 and came from multiple countries, including the United States, Canada, Japan, Sweden, and New Zealand. Most recruited through hospitals, eating-disorder programs, or specialty clinics; research samples were also included. These were not estimates from a representative survey of GA residents.
Importantly, all 52 studies did not contribute to every calculation. The overall SUD estimate came from 15 studies involving 3,118 participants. The subtype estimates used their own study sets and participant totals, as reported below.
2021 review: pooled SUD estimates in the included multi-country anorexia samples
| Population | Prevalence and 95% confidence interval | Studies and participants | Heterogeneity, I² |
|---|---|---|---|
| Anorexia nervosa overall | 16%; 11% to 20% | 15 studies; 3,118 participants | 86.3% |
| Binge-eating/purging type, AN-BP | 18%; 12% to 26% | 6 studies; 1,058 participants | 82.1% |
| Restricting type, AN-R | 7%; 4% to 10% | 8 studies; 1,635 participants | 69.3% |
The confidence intervals show uncertainty around the pooled estimates. Heterogeneity describes variation across study results, not the proportion of participants with a disorder. The high I² values are an important warning against treating the pooled percentages as fixed rates that apply everywhere. Dividing the evidence by subtype reduced some variation but did not eliminate it.
Nor should the overall estimate be reconstructed by averaging the two subtype percentages. These analyses used different contributing samples. The defensible finding is that the review reported higher SUD prevalence in its AN-BP samples than in its AN-R samples, while retaining substantial limitations around both estimates.
Why do estimates differ across diagnoses and settings?
Estimates differ because studies may examine different diagnoses, substances, time periods, and participant groups. A percentage cannot select appropriate treatment-plan components on its own. Likewise, clarifying available outpatient services requires attention to the person's needs rather than assuming that membership in a research category establishes a service match.
The anorexia review's limitations section identifies differences in measurement as one likely source of heterogeneity. Included studies used methods such as self-report, informant reports, structured interviews, and urine drug screens. Diagnostic criteria also varied across editions of the Diagnostic and Statistical Manual of Mental Disorders. A pooled result combines findings produced under those differing methods rather than removing their differences.
Time period matters too. The authors initially examined lifetime and period prevalence separately, then combined them after finding minimal variation between those categories in their analyses. That decision helps explain what the overall estimate contains. It should not be relabeled as the percentage currently experiencing both disorders or the percentage who will develop an SUD later.
Diagnosis is another boundary. AN-BP and AN-R are subtypes within anorexia nervosa. Their estimates are not separate estimates for bulimia nervosa or binge-eating disorder. A finding within one diagnosis cannot establish the same rate in another simply because both belong to the broader eating-disorder category.
The 2021 article's introduction also discusses an earlier meta-analysis spanning eating disorders and estimates involving people seeking treatment for substance-related concerns. Those are secondary contextual references, not additional results from its own anorexia-specific analysis. The introduction does not provide enough matching population and setting detail to treat those figures as directly comparable estimates for adults in GA.
The direction of the question changes the denominator. Asking how many people with an eating disorder have an SUD starts with an eating-disorder population. Asking how many people receiving SUD treatment have an eating disorder starts with a substance-treatment population. These percentages cannot be reversed, averaged together, or treated as interchangeable measures of the same group.
Recruitment further limits interpretation. A treatment-seeking sample describes people who reached that setting, not everyone in the community. In the anorexia review, the predominance of young women and clinical recruitment limits generalizability. The authors specifically caution that their findings are less applicable to males and older populations. That limitation concerns the evidence base, not whether those groups can experience serious concerns.
Does co-occurrence establish a causal relationship?
No. Finding two conditions together does not establish that one caused the other. An individualized care framework concerns current needs and treatment components, while questions for outpatient admissions concern available services. Neither replaces qualified evaluation of a person's history or turns a population association into an explanation for that individual.
The review authors explicitly state that their observational review cannot determine causal relationships between substance use, substance use disorders, and anorexia nervosa. This is a central limit of the findings, not a minor qualification. Prevalence describes how common a measured condition was in the samples studied; it does not establish a sequence of events.
The authors discuss possible explanations for overlap, including shared risk factors and overlapping behavioral or reward-related processes. These remain explanatory hypotheses in this context. Their discussion does not establish that every person has the same mechanism, that an eating disorder is simply another form of substance addiction, or that one diagnosis can stand in for the other.
Study quality also matters. The review's average quality score was 10.9 out of 15 on its modified assessment instrument, which the authors characterized as mostly moderate quality. Most included studies failed to account for the effects of significant covariates. That limits how confidently differences between groups can be attributed to the eating-disorder subtype rather than other relevant characteristics.
A large participant total does not erase these issues. More observations can improve the amount of information available, but they do not automatically make unlike samples comparable or remove measurement differences. The strongest practical reading preserves both findings at once: co-occurrence is documented, and the reasons for it cannot be settled by these pooled prevalence estimates.
What should adults in GA take from this evidence?
Take both concerns seriously without treating a research percentage as a personal diagnosis or treatment recommendation. River City Recovery's guide to individualized addiction treatment plans explains general whole-person planning, while its contact page describes adult outpatient addiction and mental health services based in Columbus, GA. Neither establishes specialty eating-disorder care or suitability for a particular eating-disorder presentation.
The NIMH overview emphasizes medical seriousness and early detection: eating disorders can be life-threatening, and early detection and treatment are important for recovery. It also states that eating disorders can be treated successfully. These statements support seeking qualified evaluation without promising a particular outcome or suggesting that a prevalence finding identifies the right treatment.
A conversation about care can distinguish what is available locally from what still needs evaluation. Useful questions concern the service's actual scope rather than whether it uses broad terms such as whole-person or individualized care:
- Does the service provide specialty eating-disorder assessment and treatment, or only general addiction and mental health care?
- How are concerns outside the program's outpatient scope addressed?
- What assessment is needed before deciding whether the setting fits?
- Would care require another clinician, specialty service, or different setting?
River City Recovery admissions can discuss its adult outpatient options in Georgia at 706-617-4970. Contact does not guarantee enrollment or a particular combination of services. Its published contact information advises against including sensitive health details in the message form. Confirming scope directly is different from assuming that a general mental health service treats every condition discussed in health education.
Routine information gathering should remain separate from urgent help. NIMH advises calling 911 in life-threatening situations. For someone struggling or having thoughts of suicide, it identifies the 988 Suicide & Crisis Lifeline, available by calling or texting 988. An admissions inquiry or research article should not delay appropriate emergency or crisis assistance.
Frequently asked questions
Can eating disorders and substance use disorders occur together?
Yes. NIMH identifies substance use disorders among the mental illnesses that can co-occur with eating disorders. A systematic review also documented this overlap in anorexia nervosa samples. Co-occurrence does not mean everyone has both conditions, and reported substance use alone does not establish a substance use disorder.
Does one eating-disorder subtype have the same evidence as another?
No. The 2021 anorexia review reported different pooled SUD estimates for binge-eating/purging and restricting subtypes, using different contributing samples. Those findings cannot automatically describe bulimia nervosa, binge-eating disorder, or every adult with an eating disorder. Diagnosis, participant characteristics, measurement methods, and recruitment settings all limit comparisons.
Do prevalence estimates prove that one disorder causes the other?
No. Prevalence estimates describe how common a measured condition was within the populations studied. The anorexia review explicitly states that its observational evidence cannot determine causal relationships. Shared risk factors and overlapping processes may be investigated as explanations, but the pooled percentages do not establish why a particular person's conditions developed.
Do these findings identify a treatment or confirm eating-disorder care at River City Recovery?
No. Prevalence research does not select an individual's treatment, and the verified River City Recovery information establishes adult outpatient addiction and mental health care, not specialty eating-disorder services. Admissions can clarify available outpatient options and scope. Eating-disorder concerns require qualified evaluation rather than assumptions based on a general program description.

